title: Kidney - 33794

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 30
Primary Site: Kidney
Histology: Conventional (clear cell) renal carcinoma


title: Breast - 33792

status: Public on Sep 30 2005

type: RNA

city: Phoenix

first: Erin

last: Curley

state: AZ

address: 445 N. 5th Street

country: USA

institute: IGC

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 60
Mammogram: Yes
Number of years in which a mammogram was obtained?: 21-25
Oral contraceptives?: Yes
Number of years of use? (Oral contraceptives): 6-10
Oophorectomy?: No
Fibrocystic disease?: Yes
Mammogram calcifications?: Yes
Hormonal therapy (# of Years)?: 6-10
Pathological T: 2
Pathological N: 1a
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Negative
Pathological PR: Negative
Primary Site: Breast
Histology: Ductal Carcinoma

molecule: total RNA

organism: Homo sapiens

source_name: Breast


title: Rectosigmoid - 33791

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 16-20
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 30
Pathological T: 3c
Pathological N: 0
Pathological M: 0
Pathological Stage: 3C
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Fallopian Tube
Histology: Metastatic Papillary serous carcinoma

source_name: Rectosigmoid


title: Breast - 31577

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 80-90
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 40
Mammogram: Yes
Number of years in which a mammogram was obtained?: 0-5
Oral contraceptives?: No
Oophorectomy?: Yes
Fibrocystic disease?: No
Mammogram calcifications?: No
Hormonal therapy (# of Years)?: 0-5
Primary Site: Breast
Histology: Ductal Carcinoma


title: Breast - 31588

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 0-5
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 18
Mammogram: Yes
Number of years in which a mammogram was obtained?: 0-5
Oral contraceptives?: No
Pathological T: 2
Pathological N: 0(i-)
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Breast
Histology: Ductal Carcinoma


title: Breast - 31883

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 30
Mammogram: Yes
Number of years in which a mammogram was obtained?: 26-30
Oral contraceptives?: Yes
Number of years of use? (Oral contraceptives): 16-20
Oophorectomy?: No
Fibrocystic disease?: No
Mammogram calcifications?: No
Pathological T: 1c
Pathological N: 1a
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Positive
Pathological PR: Negative
Pathological HER/2 Neu: Negative
Primary Site: Breast
Histology: Ductal Carcinoma


title: Rectum - 36310

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 26-30
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Presenting Symptoms: Black tarry stools
Presenting Symptoms: Diarrhea
Screening studies performed?: No
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 0
Pathological M: 1
Pathological Metastatic Sites: Hepatic
Pathological Stage: 4
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Rectum
Histology: Adenocarcinoma

source_name: Rectum


title: Kidney - 31581

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 36-40
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 90
Clinical T: 1a
Clinical N: 0
Clinical Grade: 4
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Conventional (clear cell) renal carcinoma

source_name: Kidney


title: Renal Pelvis - 31585

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 36-40
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 40
Primary Site: Renal Pelvis
Histology: Urothelial (transitional cell) carcinoma

source_name: Renal Pelvis


title: Ovary - 33793

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 36-40
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 3
Presenting Symptoms: Abdominal pain
Presenting Symptoms: Bloating
Primary Site: Ovary
Histology: Papillary Serous Carcinoma

source_name: Ovary


title: Colon - 31575

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 80-90
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 26-30
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 30
Presenting Symptoms: Abdominal Pain
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: B
Primary Site: Colon
Histology: Adenocarcinoma

source_name: Colon


title: Parotid Gland - 31580

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 60-70
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 36-40
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 21
Presenting Symptoms: Difficulties in swallowing
Presenting Symptoms: Voice changes
Pathological Question: Histology
Pathological Value: Keratinizing Squamous Cell Carcinoma
Pathological Question: T
Pathological Value: 4b
Pathological Question: N
Pathological Value: 2b
Pathological Question: M
Pathological Value: 0
Pathological Question: Stage
Pathological Value: 4B
Pathological Question: Grade
Pathological Value: 2
Pathological Question: Multiple Tumors
Pathological Value: No
Pathological Question: Stage During or Following Multimodality Theraphy
Pathological Value: No
Primary Site: Parotid Gland

source_name: Parotid Gland


title: Stomach - 31589

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 0-5
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Have you ever had esophagitis/reflux?: Yes
Pathological T: 2a
Pathological N: 0
Pathological M: 0
Pathological Stage: 1B
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Stomach
Histology: Adenocarcinoma

source_name: Stomach


title: Colon - 21957

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 80-90
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 56-60
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 14
Screening studies performed?: Yes
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 1
Pathological M: 0
Pathological Stage: 3B
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: C
Primary Site: Colon
Histology: Adenocarcinoma


title: Ovary - 31574

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 2
Presenting Symptoms: Abdominal pain
Presenting Symptoms: Bloating
Pathological T: 3c
Pathological N: 1
Pathological M: 1
Pathological Metastatic Sites: Pleura
Pathological Stage: 4
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Ovary
Histology: Papillary Serous Carcinoma


title: Breast - 31593

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 45
Mammogram: Yes
Number of years in which a mammogram was obtained?: 0-5
Oral contraceptives?: Yes
Number of years of use? (Oral contraceptives): 0-5
Oophorectomy?: No
Fibrocystic disease?: No
Mammogram calcifications?: Yes
Pathological T: 1c
Pathological N: 1a
Pathological Grade: 1
Pathological Multiple Tumors: Yes
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Positive
Pathological PR: Negative
Pathological HER/2 Neu: Positive
Primary Site: Breast
Histology: Ductal Carcinoma


title: Thyroid - 21958

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 50-60
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 41-45
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 35
Primary Site: Thyroid
Histology: Papillary carcinoma, tall cell variant

source_name: Thyroid


title: Breast - 31586

description:
Quality metric = 28S to 18S: 1
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 30
Mammogram: Yes
Number of years in which a mammogram was obtained?: 21-25
Oral contraceptives?: No
Fibrocystic disease?: Yes
Mammogram calcifications?: No
Hormonal therapy (# of Years)?: 11-15
Pathological T: 3
Pathological N: 0(i-)
Pathological M: 0
Pathological Stage: 2B
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Breast
Histology: Ductal Carcinoma


title: Omentum - 21955

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Prior Therapy: Surgical
Relapse Since Primary Treatment: Yes
Number of Years Until Relapse: 6-10
Retreatment T: 3c
Retreatment N: 0
Retreatment M: 0
Retreatment Stage: 3C
Retreatment Grade: X
Primary Site: Ovary
Histology: Metastatic Malignant granulosa cell tumor

source_name: Omentum


title: Appendix - 22206

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 6-10
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 16
Number of Years Until Relapse: None
Number of years in which a mammogram was obtained?: None
Number of years of use? (Oral contraceptives): None
Hormonal therapy (# of Years)?: None
Presenting Symptoms: Abdominal pain
Presenting Symptoms: Bloating
Pathological T: 4
Pathological N: 1
Pathological M: 1
Pathological Metastatic Sites: Peritoneum
Pathological Stage: 4
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Appendix
Histology: Signet Ring Cell Carcinoma

source_name: Appendix


title: Kidney - 28971

description:
Quality metric = 28S to 18S: 1.5
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 16
Primary Site: Kidney
Histology: Conventional (clear cell) renal carcinoma


title: Lung - 4455

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 36-40
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 60
Workplace or household smokers?: No
Pathological T: 1
Pathological N: 0
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Lung
Histology: Adenocarcinoma, NOS

source_name: Lung


title: Breast - 21949

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 8
Mammogram: No
Oral contraceptives?: No
Oophorectomy?: No
Fibrocystic disease?: No
Pathological T: 1c
Pathological N: 1a
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Positive
Pathological PR: Positive
Pathological HER/2 Neu: Positive
Primary Site: Breast
Histology: Ductal Carcinoma


title: Vulva - 21767

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 80-90
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 30
Pathological T: 2
Clinical N: 0
Clinical M: 0
Clinical Stage: 2
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Vulva
Histology: Basal Cell carcinoma, NOS

source_name: Vulva


title: Soft tissue of shoulder - 21655

description:
Quality metric = 28S to 18S: 1.5
Patient Age: 80-90
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Prior Therapy: Surgical
Relapse Since Primary Treatment: Yes
Number of Years Until Relapse: 6-10
Primary Site: Melanoma of Skin
Histology: Metastatic Malignant melanoma, NOS

source_name: Soft tissue of shoulder


title: Omentum - 21765

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 60-70
Gender: Female
Ethnic Background: African-American
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 7
Pathological T: 3c
Pathological N: X
Pathological M: 0
Pathological Stage: 3C
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Ovary
Histology: Metastatic Papillary Serous Adenocarcinoma


title: Endometrium - 21752

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 60-70
Gender: Female
Ethnic Background: African-American
Tobacco Use : Yes
Years of Tobacco Use: 0-5
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 90
Pathological T: 3a
Pathological N: X
Pathological M: 1
Pathological Metastatic Sites: Other
Pathological Stage: 4B
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Serous adenocarcinoma (papillary serous)

source_name: Endometrium


title: Ovary - 21758

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 30
Presenting Symptoms: Bloating
Primary Site: Ovary
Histology: Mucinous Adenocarinoma


title: Endometrium - 21750

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 80-90
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 21
Pathological T: 1a
Pathological N: 0
Pathological M: 0
Pathological Stage: 1A
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Mixed endometrioid and serous adenocarcinoma


title: Kidney - 21764

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 56-60
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 14
Pathological T: 3b
Pathological N: 0
Pathological M: 0
Pathological Stage: 3
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Conventional (clear cell) renal carcinoma


title: Uterus - 21760

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 14
Pathological T: 1c
Pathological N: 0
Pathological M: 0
Pathological Stage: 1C
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Endometrioid carcinoma

source_name: Uterus


title: Prostate - 21773

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 6-10
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 7
Cancer discovered by digital exam?: No
Pathological T: 2c
Pathological N: 0
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Gleason Score: 5-6
Primary Site: Prostate
Histology: Adenocarcinoma, Acinar Type

source_name: Prostate


title: Uterus - 21762

description:
Quality metric = 28S to 18S: 1
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 30
Pathological T: 1c
Pathological N: 0
Pathological M: 0
Pathological Stage: 1C
Pathological Grade: 1
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Endometrioid carcinoma


title: Colon - 21651

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 70-80
Gender: Male
Ethnic Background: American Indian
Tobacco Use : Yes
Years of Tobacco Use: 16-20
Type of Tobacco Use: Cigarettes
Type of Tobacco Use: Pipe
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Screening studies performed?: Yes
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 2
Pathological Multiple Tumors: Yes
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: B
Primary Site: Colon
Histology: Adenocarcinoma


title: Colon - 21659

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 36-40
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 21
Screening studies performed?: Yes
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: B
Primary Site: Colon
Histology: Adenocarcinoma


title: Omentum - 21766

description:
Quality metric = 28S to 18S: 1.5
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 30
Presenting Symptoms: Bright red stools
Screening studies performed?: No
Pathological T: 4
Pathological N: 1
Pathological M: 1
Pathological Metastatic Sites: Other
Pathological Stage: 4
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Colon
Histology: Metastatic Mucinous Carcinoma


title: Urinary Bladder - 21757

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 17
Primary Site: Urinary Bladder
Histology: Papillary Carcinoma

source_name: Urinary Bladder


title: Colon - 21756

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 60-70
Gender: Female
Ethnic Background: African-American
Tobacco Use : Yes
Years of Tobacco Use: 0-5
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Prior Therapy: Chemotherapy
Retreatment T: X
Retreatment N: X
Retreatment M: 1
Retreatment Metastatic Sites: Hepatic
Retreatment Stage: 4
Retreatment Grade: X
Primary Site: Colon
Histology: Colloid Carcinoma


title: Breast - 21650

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 80-90
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 14
Mammogram: Yes
Number of years in which a mammogram was obtained?: 31-35
Oral contraceptives?: No
Oophorectomy?: Yes
Fibrocystic disease?: Yes
Mammogram calcifications?: No
Hormonal therapy (# of Years)?: 21-25
Pathological T: 2
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Positive
Pathological PR: Positive
Pathological HER/2 Neu: Negative
Primary Site: Breast
Histology: Ductal Carcinoma

source_name: Breast


title: Colon - 21754

description:
Quality metric = 28S to 18S: 1.5
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 36-40
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 5
Presenting Symptoms: Abdominal Pain
Presenting Symptoms: Vomiting
Screening studies performed?: No
Diagnosis made by: Colonoscopy
Pathological T: 4
Pathological N: 2
Pathological M: 1
Pathological Metastatic Sites: Hepatic
Pathological Stage: 4
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Colon
Histology: Adenocarcinoma


title: Ureterovesicle junction - 21759

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 50
Pathological T: 3
Pathological N: 0
Pathological M: 0
Pathological Stage: 3
Pathological Grade: 3
Pathological Multiple Tumours: No
Pathological Staged During or Following Multimodality Theraphy: No
Primary Site: Ureterovesicle junction
Histology: Urothelial (transitional cell) carcinoma

source_name: Ureterovesicle junction


title: Kidney - 21772

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 40-50
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 16-20
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Clinical T: 1b
Clinical N: X
Clinical M: 1
Clinical Metastatic Sites: Osseous
Clinical Stage: 4
Clinical Grade: 3
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Conventional (clear cell) renal carcinoma

source_name: Kidney


title: Breast - 21753

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 90
Mammogram: Yes
Number of years in which a mammogram was obtained?: 11-15
Oral contraceptives?: Yes
Number of years of use? (Oral contraceptives): 0-5
Oophorectomy?: No
Fibrocystic disease?: Yes
Mammogram calcifications?: No
Hormonal therapy (# of Years)?: 11-15
Pathological T: 1b
Pathological N: 0(i-)
Pathological Grade: 1
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Breast
Histology: Ductal Carcinoma


title: Colon - 21751

description:
Quality metric = 28S to 18S: 1.5
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 14
Presenting Symptoms: Bright red stools
Screening studies performed?: No
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 1
Pathological M: 0
Pathological Stage: 3B
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: C
Primary Site: Colon
Histology: Adenocarcinoma


title: Rectosigmoid - 21951

description:
Quality metric = 28S to 18S: 1
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 24
Presenting Symptoms: Abdominal Pain
Presenting Symptoms: Bright red stools
Presenting Symptoms: Constipation
Presenting Symptoms: Diarrhea
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 1
Pathological M: 0
Pathological Stage: 3B
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: C
Primary Site: Rectosigmoid
Histology: Adenocarcinoma

source_name: Rectosigmoid


title: Colon - 21755

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 90-100
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 7
Screening studies performed?: No
Diagnosis made by: Colonoscopy
Pathological T: 2
Pathological N: 0
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Colon
Histology: Adenocarcinoma

source_name: Colon


title: Omentum - 21771

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 40-50
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Days from Patient Diagnosis to Excision: 7
Pathological T: 3a
Pathological N: X
Pathological M: 1
Pathological Metastatic Sites: Other
Pathological Stage: 4B
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Metastatic Endometrioid carcinoma


title: Pelvic mass - 33795

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 26-30
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 18
Pathological T: 3a
Pathological N: X
Pathological M: 1
Pathological Metastatic Sites: Other
Pathological Stage: 4B
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Malignant mixed Mullerian tumor

source_name: Pelvic mass


title: Omentum - 21763

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 16-20
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 17
Presenting Symptoms: Abdominal mass
Presenting Symptoms: Abdominal pain
Presenting Symptoms: Bloating
Pathological T: 3c
Pathological N: X
Pathological M: 0
Pathological Stage: 3C
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Ovary
Histology: Metastatic Papillary Serous Adenocarcinoma


title: Colon - 21638

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 41-45
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 75
Screening studies performed?: Yes
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 4
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: B
Primary Site: Colon
Histology: Adenocarcinoma


title: Prostate - 20464

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 4
PSA: Elevated
# of years PSA Tested?: 6-10
Cancer discovered by digital exam?: No
Pathological T: 2c
Pathological N: 0
Pathological M: 0
Pathological Stage: 2
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Gleason Score: 5-6
Primary Site: Prostate
Histology: Adenocarcinoma, NOS


title: Kidney - 21634

description:
Quality metric = 28S to 18S: 1
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 41-45
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 14
Pathological T: 2
Pathological N: 0
Pathological M: 0
Pathological Stage: 2
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Conventional (clear cell) renal carcinoma


title: Breast - 20459

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 40-50
Gender: Female
Ethnic Background: Hispanic
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 25
Mammogram: Yes
Number of years in which a mammogram was obtained?: 0-5
Oral contraceptives?: Yes
Number of years of use? (Oral contraceptives): 0-5
Oophorectomy?: No
Fibrocystic disease?: Yes
Mammogram calcifications?: Yes
Pathological T: 2
Pathological N: 1a
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Positive
Pathological PR: Negative
Pathological HER/2 Neu: Positive
Primary Site: Breast
Histology: Ductal Carcinoma


title: Colon - 21637

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 50-60
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 9
Presenting Symptoms: Abdominal Pain
Presenting Symptoms: Black tarry stools
Presenting Symptoms: Bright red stools
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 1
Pathological M: 0
Pathological Stage: 3B
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: C
Primary Site: Colon
Histology: Adenocarcinoma


title: Endometrium - 20319

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 56
Pathological T: 1c
Pathological N: 0
Pathological M: 0
Pathological Stage: 1C
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Endometrioid carcinoma


title: Breast - 21633

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 26-30
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 21
Mammogram: Yes
Number of years in which a mammogram was obtained?: 16-20
Oral contraceptives?: Yes
Number of years of use? (Oral contraceptives): 0-5
Oophorectomy?: No
Fibrocystic disease?: No
Mammogram calcifications?: No
Pathological T: 1c
Pathological N: 0(i-)
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Breast
Histology: Ductal Carcinoma


title: Colon - 20327

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 50-60
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 36-40
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 30
Prior Therapy: Chemotherapy
Prior Therapy: Surgical
Relapse Since Primary Treatment: Yes
Number of Years Until Relapse: 0-5
Screening studies performed?: No
Diagnosis made by: Colonoscopy
Retreatment T: 4
Retreatment N: 1
Retreatment M: 1
Retreatment Metastatic Sites: Hepatic
Retreatment Stage: 4
Retreatment Grade: 2
Primary Site: Colon
Histology: Metastatic Adenocarcinoma


title: Ovary - 20325

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 17
Presenting Symptoms: Abdominal mass
Pathological T: 3c
Pathological N: X
Pathological M: 1
Pathological Metastatic Sites: Pleura
Pathological Stage: 4
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Ovary
Histology: Serous Adenocarinoma

source_name: Ovary


title: Kidney - 20320

description:
Quality metric = 28S to 18S: 1
Patient Age: 50-60
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 36-40
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 55
Clinical T: 1a
Clinical N: 0
Clinical M: 0
Clinical Stage: 1
Clinical Grade: 2
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Conventional (clear cell) renal carcinoma


title: Kidney - 20313

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 50-60
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 16-20
Type of Tobacco Use: Cigarettes
Type of Tobacco Use: Pipe
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 60
Clinical T: 2
Clinical N: 0
Clinical M: 0
Clinical Stage: 2
Clinical Grade: 4
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Conventional (clear cell) renal carcinoma


title: Colon - 20310

description:
Quality metric = 28S to 18S: 1.7
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 24
Presenting Symptoms: Bright red stools
Screening studies performed?: No
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 1
Pathological M: 0
Pathological Stage: 3B
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: C
Primary Site: Colon
Histology: Adenocarcinoma


title: Duodenum - 20318

description:
Quality metric = 28S to 18S: 1
Patient Age: 40-50
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 31-35
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 180
Pathological T: 4
Pathological N: 0
Pathological M: 0
Pathological Stage: 2
Pathological Grade: 3
Pathological Multiple Tumours: No
Pathological Staged During or Following Multimodality Theraphy: No
Primary Site: Duodenum
Histology: Adenocarcinoma

source_name: Duodenum


title: Kidney - 20463

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 30-40
Gender: Female
Ethnic Background: Hispanic
Tobacco Use : Yes
Years of Tobacco Use: 16-20
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 30
Clinical T: 1a
Clinical N: 0
Clinical M: 0
Clinical Stage: 1
Clinical Grade: 1
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Conventional (clear cell) renal carcinoma


title: Omentum - 20311

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 14
Presenting Symptoms: Bloating
Pathological T: 3c
Pathological N: X
Pathological M: 0
Pathological Stage: 3C
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Ovary
Histology: Metastatic Papillary Serous Carcinoma

source_name: Omentum


title: Ovary - 20307

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 75
Prior Therapy: Chemotherapy
Presenting Symptoms: Abdominal pain
Pathological T: 3c
Pathological N: 0
Pathological M: 1
Pathological Metastatic Sites: Pleura
Pathological Stage: 4
Pathological Grade: 3
Pathological Stage During or Following Multimodality Therapy: Yes
Primary Site: Ovary
Histology: Adenocarcinoma


title: Endometrium - 20303

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 12
Pathological T: 1b
Pathological N: 0
Pathological M: 0
Pathological Stage: 1B
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Endometrioid carcinoma


title: Uterine/Bladder Tumor - 20328

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 30-40
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Alcohol Consumption?: No
Family History of Cancer?: No
Prior Therapy: Radiation
Relapse Since Primary Treatment: Yes
Number of Years Until Relapse: 0-5
Retreatment T: 4
Retreatment N: 0
Retreatment M: 0
Retreatment Stage: 4A
Retreatment Grade: 3
Primary Site: Uterine/Bladder Tumor
Histology: Squamous cell carcinoma

source_name: Uterine/Bladder Tumor


title: Ovary - 20326

description:
Quality metric = 28S to 18S: 1.5
Patient Age: 40-50
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 6-10
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 1
Primary Site: Ovary
Histology: Papillary Serous Carcinoma


title: Ovary - 20315

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 45
Presenting Symptoms: Bloating
Pathological T: 3c
Pathological N: 0
Pathological M: 0
Pathological Stage: 3C
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Ovary
Histology: Adenocarcinoma, endometrioid and papillary serous


title: Ovary - 20323

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Prior Therapy: Chemotherapy
Prior Therapy: Surgical
Relapse Since Primary Treatment: Yes
Number of Years Until Relapse: 0-5
Retreatment T: X
Retreatment N: 2
Retreatment M: 1
Retreatment Metastatic Sites: Other
Retreatment Stage: 4
Retreatment Grade: 2
Primary Site: Colon
Histology: Metastatic Adenocarcinoma


title: Liver - 20302

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 45
Clinical Question: Histology
Clinical Value: Intrahepatic Cholangiocarcinoma
Clinical Question: T
Clinical Value: 1
Clinical Question: N
Clinical Value: 0
Clinical Question: M
Clinical Value: 0
Clinical Question: Stage
Clinical Value: 1
Clinical Question: Grade
Clinical Value: 2
Clinical Question: Multiple Tumors
Clinical Value: No
Clinical Question: Stage During or Following Multimodality Theraphy
Clinical Value: No
Primary Site: Liver

source_name: Liver


title: RRE2_Chitin4

city: Stanford

first: Shauna

last: Somerville

state: CA

address: 260 Panama Street

department: Plant Biology

institute: Carnegie Institution of Washington

description:
Genotype: rre2-1 (rapid response to elicitor 2-1), a T-DNA insertion mutant (SALK_133789). RRE2 (At3g16720, alias = ATL2) encodes a protein with a RING domain found in E3 ligases. Treatment: incubated with hydrolyzed crab-shell chitin for 30 minutes.
Growth Conditions and Treatments: All experiments were performed as previously described (Ramonell et al., 2002, Mol. Plant. Pathol. 3(5), 301-311). Arabidopsis thaliana seeds were surface sterilized. Approximately 500 seeds (10 micrograms) were placed in 250 mL Erlenmeyer flasks containing 125 mL of liquid Murashige and Skoog medium (Sigma, St Louis, MO, USA) containing 2% dextrose. These flasks were incubated with gentle shaking for 14 days under constant illumination (125 µEinsteins m-2 s-1) at 22ºC. Acid-hydrolysed, crab-shell chitin (Sigma, St Louis, MO, USA) was added to give a final concentration 100 mg/L. The control flasks received an equivalent amount of sterile, double-distilled water for each treatment. Flasks were incubated for 30 minutes with the crab-shell chitin. Whole seedlings from each treatment were collected, the medium was drained, and the seedlings were rapidly forzen in liquid nitrogen. The results of four replicates are presented.
RNA and Microarray Methods: Total RNA was extracted from the plants using a modified Trizol method (Chomczynski and Sashi, 1987) (see also Protocols Manual at the AFGC web page http://www.arabidopsis.org/info/2010_projects/comp_proj/AFGC/RevisedAFGC/AFGC_Protocols_Dec_2001L.pdf) and purified with a silica membrane column (Qiagen, RNeasy). Fifteen micrograms biotinylated complementary RNA (cRNA) was prepared and used to hybridize ATH1 Arabidopsis GeneChips (Affymetrix) using the Affymetrix manufacturer’s protocols. The array images were analyzed with the Affymetrix GeneChip Operating Software (GCOS) 1.1 with the target intensity set to 500. These data were imported into GeneSpring 7.0 (Silicon Genetics, Redwood City, CA, USA). To remove chip-to-chip signal variation, each measurement was divided by the 50.0th percentile of all measurements in that sample.  All samples were normalized to the reference data set, consisting of four replicates of Columbia-0, untreated. Each measurement for each gene was divided by the median of that gene’s intensity in the reference data set. The normalized values (Normalized Ratio) are reported along with the intensity values for this array.
Keywords = chitin, defense, elicitor, mutant, PAMP, protein degradation, ring zinc finger protein, ubiquitin E3 ligase
Lot batch = 510690

organism: Arabidopsis thaliana

source_name: chitin treated mutant rre2-1 seedlings. (biological replicate: 4 of 4)


title: RRE2_Chitin3

source_name: chitin treated mutant rre2-1 seedlings. (biological replicate: 3 of 4)


title: Breast - 31570

description:
Quality metric = 28S to 18S: 1
Patient Age: 40-50
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Prior Therapy: Radiation
Prior Therapy: Surgical
Relapse Since Primary Treatment: Yes
Number of Years Until Relapse: 0-5
Mammogram: Yes
Number of years in which a mammogram was obtained?: 6-10
Oral contraceptives?: Yes
Number of years of use? (Oral contraceptives): 0-5
Mammogram calcifications?: Yes
Retreatment T: 2
Retreatment N: 0(i-)
Retreatment Grade: 3
Primary Site: Breast
Histology: Ductal Carcinoma


title: RRE2_Chitin2

source_name: chitin treated mutant rre2-1 seedlings. (biological replicate: 2 of 4)


title: Prostate - 31573

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 50-60
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 60
Presenting Symptoms: Hesitancy
Presenting Symptoms: Urgency
PSA: Elevated
# of years PSA Tested?: 0-5
Cancer discovered by digital exam?: Yes
Pathological T: 2c
Pathological N: 0
Pathological M: 0
Pathological Stage: 2
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Gleason Score: 7
Primary Site: Prostate
Histology: Adenocarcinoma, Acinar Type


title: RRE2_Chitin1

source_name: chitin treated mutant rre2-1 seedlings. (biological replicate: 1 of 4)


title: Soft Tissue Lt Shoulder/Arm - 20317

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 80-90
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 90
Pathological T: 2b
Pathological N: 0
Pathological M: 0
Pathological Stage: 3
Pathological Grade: 3
Primary Site: Soft Tissue Sarcoma
Histology: Leiomyosarcoma

source_name: Soft Tissue L Upper Arm


title: Urethral Nodule - 20300

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 29
Prior Therapy: Hormonal Treatment
Pathological T: 3b
Pathological N: 0
Pathological M: 0
Pathological Stage: 3B
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Metastatic Endometrioid carcinoma

source_name: Urethral Nodule


title: RRE2_C3

description:
Genotype: rre2-1 (rapid response to elicitor 2-1), a T-DNA insertion mutant (SALK_133789). RRE2 (At3g16720, alias = ATL2) encodes a protein with a RING domain found in E3 ligases. Treatment: untreated
Growth Conditions and Treatments: All experiments were performed as previously described (Ramonell et al., 2002, Mol. Plant. Pathol. 3(5), 301-311). Arabidopsis thaliana seeds were surface sterilized. Approximately 500 seeds (10 micrograms) were placed in 250 mL Erlenmeyer flasks containing 125 mL of liquid Murashige and Skoog medium (Sigma, St Louis, MO, USA) containing 2% dextrose. These flasks were incubated with gentle shaking for 14 days under constant illumination (125 µEinsteins m-2 s-1) at 22ºC. Acid-hydrolysed, crab-shell chitin (Sigma, St Louis, MO, USA) was added to give a final concentration 100 mg/L. The control flasks received an equivalent amount of sterile, double-distilled water for each treatment. Flasks were incubated for 30 minutes with the crab-shell chitin. Whole seedlings from each treatment were collected, the medium was drained, and the seedlings were rapidly forzen in liquid nitrogen. The results of four replicates are presented.
RNA and Microarray Methods: Total RNA was extracted from the plants using a modified Trizol method (Chomczynski and Sashi, 1987) (see also Protocols Manual at the AFGC web page http://www.arabidopsis.org/info/2010_projects/comp_proj/AFGC/RevisedAFGC/AFGC_Protocols_Dec_2001L.pdf) and purified with a silica membrane column (Qiagen, RNeasy). Fifteen micrograms biotinylated complementary RNA (cRNA) was prepared and used to hybridize ATH1 Arabidopsis GeneChips (Affymetrix) using the Affymetrix manufacturer’s protocols. The array images were analyzed with the Affymetrix GeneChip Operating Software (GCOS) 1.1 with the target intensity set to 500. These data were imported into GeneSpring 7.0 (Silicon Genetics, Redwood City, CA, USA). To remove chip-to-chip signal variation, each measurement was divided by the 50.0th percentile of all measurements in that sample.  All samples were normalized to the reference data set, consisting of four replicates of Columbia-0, untreated. Each measurement for each gene was divided by the median of that gene’s intensity in the reference data set. The normalized values (Normalized Ratio) are reported along with the intensity values for this array.
Keywords = chitin, defense, elicitor, mutant, PAMP, protein degradation, ring zinc finger protein, ubiquitin E3 ligase
Lot batch = 510690

source_name: untreated mutant rre2-1 seedlings. (biological replicate: 3 of 4)


title: Col_C2

description:
Genotype: Columbia-0, wild-type; Treatment: untreated
Growth Conditions and Treatments: All experiments were performed as previously described (Ramonell et al, 2002, Mol. Plant. Pathol. 3(5), 301-311). Arabidopsis thaliana seeds were surface sterilized. Approximately 500 seeds(10 microgram) were placed in 250 mL erlenmeyer flasks containing 125 mL of liquid Murashige and Skoog medium (Sigma, St Louis, MO, USA) containing 2% dextrose. These flasks were incubated with gentle shaking for 14 days under constant illumination (125 µEinsteins m-2 s-1) at 22ºC. After this time, acid-hydrolysed, crab-shell chitin (Sigma, St Louis, MO, USA) was added to give a final concentration 100 mg/L. The control flasks received an equivalent amount of sterile, double-distilled water for each treatment. Flasks were incubated for 30 minutes with the crab-shell chitin. Whole seedlings from each treatment were collected, the medium was drained, and the seedlings were rapidly forzen in liquid nitrogen. The results of four replicates are presented.
RNA and Microarray Methods: Total RNA was extracted from the plants using a modified Trizol method (Chomczynski and Sashi, 1987) (see also Protocols Manual at the AFGC web page http://www.arabidopsis.org/info/2010_projects/comp_proj/AFGC/RevisedAFGC/AFGC_Protocols_Dec_2001L.pdf) and purified with a silica membrane column (Qiagen, RNeasy). Fifteen micrograms biotinylated complementary RNA (cRNA) was prepared and used to hybridize ATH1 Arabidopsis GeneChips (Affymetrix) using the Affymetrix manufacturer’s protocols. The array images were analyzed with the Affymetrix GeneChip Operating Software (GCOS) 1.1 with the target intensity set to 500. These data were imported into GeneSpring 7.0 (Silicon Genetics, Redwood City, CA, USA). To remove chip-to-chip signal variation, each measurement was divided by the 50.0th percentile of all measurements in that sample.  All samples were normalized to the reference data set, consisting of four replicates of Columbia-0, untreated. Each measurement for each gene was divided by the median of that gene’s intensity in the reference data set. The normalized values (Normalized Ratio) are reported along with the intensity values for this array.
Keywords = chitin, defense, elicitor, mutant, powdery mildew, Botrytis cinerea, ring zinc finger, ubiquitin, ATL, RRE, At2g35000, At3g16720
Lot batch = 510690

source_name: untreated wild type Col-0 seedlings. (biological replicate: 2 of 4)


title: Breast - 20301

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 10
Mammogram: Yes
Number of years in which a mammogram was obtained?: 11-15
Oral contraceptives?: No
Oophorectomy?: Yes
Fibrocystic disease?: Yes
Mammogram calcifications?: Yes
Hormonal therapy (# of Years)?: 11-15
Pathological T: 2
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Positive
Pathological PR: Positive
Pathological HER/2 Neu: Negative
Primary Site: Breast
Histology: Ductal Carcinoma

source_name: Breast


title: Col_Chitin3

source_name: chitin treated wild type Col-0 seedlings. (biological replicate: 3 of 4)


title: Col_Chitin1

source_name: chitin treated wild type Col-0 seedlings. (biological replicate: 1 of 4)


title: RRE2_C2

source_name: untreated mutant rre2-1 seedlings. (biological replicate: 2 of 4)


title: RRE2_C1

source_name: untreated mutant rre2-1 seedlings. (biological replicate: 1 of 4)


title: Col_Chitin4

source_name: chitin treated wild type Col-0 seedlings. (biological replicate: 4 of 4)


title: Col_C4

source_name: untreated wild type Col-0 seedlings. (biological replicate: 4 of 4)


title: Col_Chitin2

source_name: chitin treated wild type Col-0 seedlings. (biological replicate: 2 of 4)


title: Breast - 20291

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 40-50
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 15
Mammogram: Yes
Number of years in which a mammogram was obtained?: 0-5
Oral contraceptives?: No
Oophorectomy?: No
Fibrocystic disease?: No
Pathological T: 2
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Negative
Pathological PR: Negative
Pathological HER/2 Neu: Negative
Primary Site: Breast
Histology: Ductal Carcinoma


title: RRE2_C4

source_name: untreated mutant rre2-1 seedlings. (biological replicate: 4 of 4)


title: RRE1_Chitin1

description:
Genotype: rre1-1 (rapid response to elicitor 1-1), a T-DNA insertion mutant (SALK_066755). RRE1 (At2g35000) enocdes a protein with a RING domain found in ubiqitin E3 ligases. Treatment: incubated with hydrolyzed crab-shell chitin for 30 minutes.
Growth Conditions and Treatments: All experiments were performed as previously described (Ramonell et al., 2002, Mol. Plant. Pathol. 3(5), 301-311). Arabidopsis thaliana seeds were surface sterilized. Approximately 500 seeds (10 micrograms) were placed in 250 mL Erlenmeyer flasks containing 125 mL of liquid Murashige and Skoog medium (Sigma, St Louis, MO, USA) containing 2% dextrose. These flasks were incubated with gentle shaking for 14 days under constant illumination (125 µEinsteins m-2 s-1) at 22ºC. Acid-hydrolysed, crab-shell chitin (Sigma, St Louis, MO, USA) was added to give a final concentration 100 mg/L. The control flasks received an equivalent amount of sterile, double-distilled water for each treatment. Flasks were incubated for 30 minutes with the crab-shell chitin. Whole seedlings from each treatment were collected, the medium was drained, and the seedlings were rapidly forzen in liquid nitrogen. The results of four replicates are presented.
RNA and Microarray Methods: Total RNA was extracted from the plants using a modified Trizol method (Chomczynski and Sashi, 1987) (see also Protocols Manual at the AFGC web page http://www.arabidopsis.org/info/2010_projects/comp_proj/AFGC/RevisedAFGC/AFGC_Protocols_Dec_2001L.pdf) and purified with a silica membrane column (Qiagen, RNeasy). Fifteen micrograms biotinylated complementary RNA (cRNA) was prepared and used to hybridize ATH1 Arabidopsis GeneChips (Affymetrix) using the Affymetrix manufacturer’s protocols. The array images were analyzed with the Affymetrix GeneChip Operating Software (GCOS) 1.1 with the target intensity set to 500. These data were imported into GeneSpring 7.0 (Silicon Genetics, Redwood City, CA, USA). To remove chip-to-chip signal variation, each measurement was divided by the 50.0th percentile of all measurements in that sample.  All samples were normalized to the reference data set, consisting of four replicates of Columbia-0, untreated. Each measurement for each gene was divided by the median of that gene’s intensity in the reference data set. The normalized values (Normalized Ratio) are reported along with the intensity values for this array.
Keywords = chitin, defense, elicitor, mutant, PAMP, protein degradation, ring zinc finger protein, ubiquitin E3 ligase
Lot batch = 510690

source_name: chitin treated mutant rre1-1 seedlings. (biological replicate: 1 of 4)


title: Ovary - 20284

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 30
Primary Site: Ovary
Histology: Serous Adenocarinoma

source_name: Ovary


title: Col_C3

source_name: untreated wild type Col-0 seedlings. (biological replicate: 3 of 4)


title: Stomach - 20293

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 11-15
Type of Tobacco Use: Cigars
Alcohol Consumption?: Yes
Family History of Cancer?: No
Have you ever had esophagitis/reflux?: Yes
Pathological T: 3
Pathological N: 1
Pathological M: 1
Pathological Metastatic Sites: Peritoneum
Pathological Stage: 4
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Stomach
Histology: Signet Ring Cell Carcinoma

source_name: Stomach


title: Breast - 20292

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 20-30
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 0-5
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 5
Mammogram: No
Oral contraceptives?: Yes
Number of years of use? (Oral contraceptives): 0-5
Oophorectomy?: No
Fibrocystic disease?: No
Mammogram calcifications?: No
Pathological T: 2
Pathological N: 1a
Pathological M: 0
Pathological Stage: 2B
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Positive
Pathological PR: Positive
Primary Site: Breast
Histology: Ductal Carcinoma


title: Colon - 20286

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 11-15
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Prior Therapy: Chemotherapy
Prior Therapy: Surgical
Relapse Since Primary Treatment: Yes
Number of Years Until Relapse: 0-5
Retreatment T: 3c
Retreatment N: X
Retreatment M: 0
Retreatment Stage: 3C
Retreatment Grade: 3
Primary Site: Ovary
Histology: Metastatic Papillary Serous Adenocarcinoma

source_name: Colon


title: RRE1_Chitin3

source_name: chitin treated mutant rre1-1 seedlings. (biological replicate: 3 of 4)


title: Breast - 20294

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Days from Patient Diagnosis to Excision: 17
Mammogram: Yes
Oral contraceptives?: No
Oophorectomy?: No
Fibrocystic disease?: No
Mammogram calcifications?: Yes
Pathological T: 2
Pathological N: 2a
Pathological M: 0
Pathological Stage: 3A
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Positive
Pathological PR: Positive
Pathological HER/2 Neu: Negative
Primary Site: Breast
Histology: Ductal Carcinoma


title: Lung - 20275

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 36-40
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 75
Workplace or household smokers?: Yes
Pathological T: 1
Pathological N: 0
Pathological M: 0
Pathological Stage: 1A
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Lung
Histology: Bronchioloalveolar carcinoma

source_name: Lung


title: Endometrium - 1039

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 30-40
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 0-5
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 13
Pathological T: 1b
Pathological N: 0
Pathological Grade: 1
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Endometrioid carcinoma

source_name: Endometrium


title: Col_C1

source_name: untreated wild type Col-0 seedlings. (biological replicate: 1 of 4)


title: RRE1_Chitin2

source_name: chitin treated mutant rre1-1 seedlings. (biological replicate: 2 of 4)


title: RRE1_C3

description:
Genotype: rre1-1 (rapid response to elicitor 1-1), a T-DNA insertion mutant (SALK_066755). RRE1 (At2g35000) enocdes a protein with a RING domain found in ubiqitin E3 ligases. Treatment: untreated.
Growth Conditions and Treatments: All experiments were performed as previously described (Ramonell et al., 2002, Mol. Plant. Pathol. 3(5), 301-311). Arabidopsis thaliana seeds were surface sterilized. Approximately 500 seeds (10 micrograms) were placed in 250 mL Erlenmeyer flasks containing 125 mL of liquid Murashige and Skoog medium (Sigma, St Louis, MO, USA) containing 2% dextrose. These flasks were incubated with gentle shaking for 14 days under constant illumination (125 µEinsteins m-2 s-1) at 22ºC. Acid-hydrolysed, crab-shell chitin (Sigma, St Louis, MO, USA) was added to give a final concentration 100 mg/L. The control flasks received an equivalent amount of sterile, double-distilled water for each treatment. Flasks were incubated for 30 minutes with the crab-shell chitin. Whole seedlings from each treatment were collected, the medium was drained, and the seedlings were rapidly forzen in liquid nitrogen. The results of four replicates are presented.
RNA and Microarray Methods: Total RNA was extracted from the plants using a modified Trizol method (Chomczynski and Sashi, 1987) (see also Protocols Manual at the AFGC web page http://www.arabidopsis.org/info/2010_projects/comp_proj/AFGC/RevisedAFGC/AFGC_Protocols_Dec_2001L.pdf) and purified with a silica membrane column (Qiagen, RNeasy). Fifteen micrograms biotinylated complementary RNA (cRNA) was prepared and used to hybridize ATH1 Arabidopsis GeneChips (Affymetrix) using the Affymetrix manufacturer’s protocols. The array images were analyzed with the Affymetrix GeneChip Operating Software (GCOS) 1.1 with the target intensity set to 500. These data were imported into GeneSpring 7.0 (Silicon Genetics, Redwood City, CA, USA). To remove chip-to-chip signal variation, each measurement was divided by the 50.0th percentile of all measurements in that sample.  All samples were normalized to the reference data set, consisting of four replicates of Columbia-0, untreated. Each measurement for each gene was divided by the median of that gene’s intensity in the reference data set. The normalized values (Normalized Ratio) are reported along with the intensity values for this array.
Keywords = chitin
Keywords = defense
Keywords = elicitor
Keywords = mutant
Keywords = PAMP
Keywords = protein degradation
Keywords = ring zinc finger protein
Keywords = ubiquitin E3 ligase
Lot batch = 510690

source_name: untreated mutant rre1-1 seedlings. (biological replicate: 3 of 4)


title: RRE1_C4

source_name: untreated mutant rre1-1 seedlings. (biological replicate: 4 of 4)


title: RRE1_C2

source_name: untreated mutant rre1-1 seedlings. (biological replicate: 2 of 4)


title: RRE1_Chitin4

source_name: chitin treated mutant rre1-1 seedlings. (biological replicate: 4 of 4)


title: Breast - 20290

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 30-40
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 7
Mammogram: Yes
Number of years in which a mammogram was obtained?: 0-5
Oral contraceptives?: Yes
Oophorectomy?: No
Fibrocystic disease?: No
Pathological T: 2
Pathological N: 2a
Pathological M: 0
Pathological Stage: 3A
Pathological Grade: 1
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Positive
Pathological PR: Positive
Pathological HER/2 Neu: Negative
Primary Site: Breast
Histology: Ductal Carcinoma

source_name: Breast


title: RRE1_C1

source_name: untreated mutant rre1-1 seedlings. (biological replicate: 1 of 4)


title: S_21437514

status: Public on Sep 23 2005

city: Boston

first: Wenzhong Xiao

state: MA

address: 55 Fruit Street, GRV 1302

department: Department of Surgery

institute: Massachusetts General Hospital

description: Data for Inflamation and Host Reponse to Injury, NIH Glue Grant, Study or Experiment

hyb_protocol: Standard Affymetrix procedures

scan_protocol: Standard Affymetrix procedures

data_processing: Affymetrix GCOS version 1.2.0

label: paper supplemental material "A Network-Based Analysis of Systemic Inflammation in Humans" at www.gluegrant.org

source_name: whole blood

tag: Six healthy subjects at 0, 2, 6 hours post endotoxin administration


title: S_474471


title: S_4194863


title: S_7821833


title: S_32306462


title: S_27557812


title: S_3761772


title: S_31212545


title: S_3076586


title: S_28382210


title: S_11976839


title: S_25014370


title: S_6770098


title: S_15183281


title: S_2225401


title: S_15344636


title: Cell culture. A549 FLAP (ALOX5AP) silenced 2

status: Public on Sep 21 2005

city: Bethesda

first: Anatoly

middle: L.

last: Mayburd

state: MD

address: 9000 Rockville Pyke

department: Intervention section

institute: NIH/NCI

description: cell culture

hyb_protocol: standard Affymetrix procedures

scan_protocol: standard Affymetrix procedures

data_processing: Affymetrix Microarray Suite version 5.0

label: biotin

source_name: cell culture

label_protocol: Approximately 8 ?g of total RNA was processed to produce biotinylated cRNA targets.

extract_protocol: The cells were treated by the drug or by the solvent control, tripsinized and lysed in RLT buffer (Qiagen).Total RNA was extracted from the tissue lysate using an RNeasy kit (Qiagen).


title: Cell culture. A549 treated by HNRPA2B1 construct, control

description: cell culture


title: Cell culture. A549 treated by MK886 4

description: cell culture


title: Cell culture. H209 treated by HNRPA2B1, silenced 2

description: cell culture


title: Cell culture. A549 treated by MK886 3

description: cell culture


title: Cell culture. A549 treated by FLAP (ALOX5AP) siRNA, control

description: cell culture


title: Cell culture. H209 treated by HNRPA2B1, control 1

description: cell culture


title: Cell culture. A549 treated by HNRPA2B1, silenced 1

description: cell culture


title: Cell culture. A549 treated by MK886, control 4

description: cell culture


title: Cell culture. H720 treated by HNRPA2B1, control 2

description: cell culture


title: S_16596851


title: Cell culture. A549 FLAP (ALOX5AP) sielnced 1

description: cell culture


title: Cell culture. A549 treated by MK886, control 2

description: cell culture


title: Cell culture. A549 treated by MK886, control 1

description: cell culture


title: Cell culture. A549 treated by MK886, control 3

description: cell culture


title: Breast - 1005

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 15
Mammogram: Yes
Number of years in which a mammogram was obtained?: 6-10
Oral contraceptives?: No
Oophorectomy?: No
Fibrocystic disease?: No
Mammogram calcifications?: No
Pathological T: 2
Pathological N: 1mi
Pathological M: 0
Pathological Stage: 2B
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Positive
Pathological PR: Negative
Pathological HER/2 Neu: Positive
Primary Site: Breast
Histology: Ductal Carcinoma


title: Cell culture. A549 treated by MK886 1

description: cell culture


title: S_11971084


title: Cell culture. A549 treated by MK886 2

description: cell culture


title: Cell culture. H720 treated by HNRPA2B1 construct, silenced

description: cell culture


title: Metastatic prostate cancer W4

status: Public on Sep 20 2005

city: Ann Arbor

first: Jianjun

last: Yu

state: MI

address: 1150 W. Medical Center Dr.

department: Pathology

institute: University of Michigan

description: hormone-refractory metastatic prostate cancer tissue

source_name: Prostate

tag: Metastatic, prostate cancer


title: Metastatic prostate cancer W3


title: Clinically localized primary prostate cancer P4

description: clinically localized prostate cancer tissue

tag: Primary, localized, prostate cancer


title: Benign prostate tissue NX1

description: benign prostate tissue pool from tissue N1, N2,N3 and N4

tag: Benign, Pooled, prostate tissue


title: Metastatic prostate cancer W1

description: metastatic prostate cancer tissue

tag: metastatic, prostate cancer


title: Clinically localized primary prostate cancer tissue pool PX1

description: clinically localized prostate cancer tissue pool extracted from sample P1, P2, P3, P4 and P5

tag: Primary, localized, pooled, prostate cancer


title: Metastatic prostate cancer tissue pool WX1

description: hormone-refractory metastatic prostate cancer tissue pool extraced from sample W1, W2, W3 and W4

tag: metastatic, pooled, prostate cancer


title: Clinically localized primary prostate cancer P1

tag: Primary, Prostate cancer, localized


title: Clinically localized primary prostate cancer P3


title: Metastatic prostate cancer W2


title: Metastatic prostate cancer tissue pool WX2

description: hormone-refractory metastatic prostate cancer tissue pool from sample W1,W2,W3 and W4, replicates of WX1


title: Clinically localized primary prostate cancer P5


title: Clinically localized primary prostate cancer P2


title: Benign prostate tissue N3

description: benign prostate tissue

tag: Benign, prostate tissue


title: H720 cell line control 3

status: Public on Sep 10 2005

description: neuroendocrine non small cell lung cancer culture

label_protocol: Approximately 8 µg of total RNA was processed to produce biotinylated cRNA targets.

extract_protocol: the cell culture was grown until the clumps of 0.2-0.4 mm size were formed, upon resuspensions the clumps were easily restored, indicating a healthy culture. The cell clumps were resuspended using a 30-gauge syringe needle, and

tag: none provided


title: Benign prostate tissue N4

description: benign prostate tissue

tag: Benign, Prostate tissue


title: H720 MK886 1 micromole 24h serum free Sample 4


title: Benign prostate tissue N2

description: benign prostate tissue


title: H720 MK886 1 micromole 24h serum free Sample 2


title: H720 MK886 1 micromole 24h serum free Sample 3


title: H720 cell line control 4


title: Benign Prostate tissue N1

description: benign prostate tissue


title: Arabidopsis_Seedling04

status: Public on Aug 06 2005

city: Chicago

first: Daphne

last: Preuss

state: IL

address: 1103 E. 57th Street

department: Molecular Genetics and Cell Biology

institute: The University of Chicago

description: Seedling tissue was collected by growing Ler seedlings on Murashige and Skoog media plates for 10 days, and whole seedlings were harvested for RNA.

data_processing: statistical averaging of probes using Affymetrix software

label: Bioarray High Yield RNA Transcript Labeling Kit

source_name: plant

tag: Landsberg erecta (Ler)


title: Arabidopsis_Seedling03

growth_protocol: Seedling tissue was collected by growing Ler seedlings on Murashige and Skoog media plates for 10 days, and whole seedlings were harvested for RNA.


title: Arabidopsis_Ovary04

description: Ovary tissues were isolated from pistils after emasculating stage 8 buds (Bowman, 1994) of Landsberg erecta (Ler) flowers. After one day of growth, pistils were harvested. Stigma was seperated from ovaries using superfine tip scissors and flash frozen in liquid nitrogen until  RNA harvesting.

hyb_protocol: Affymetrix GeneChip technology

source_name: plant ovaries

tag: Landsberg erecta (Ler) flowers


title: H720 cell line control 2


title: Clinically localized primary prostate cancer tissue pool PX2

description: clinically localized prostate cancer tissue pool extracted from sample P1, P2, P3, P4 and P5, replicates of PX1.

tag: Primary, localized, pooled tissue, prostate cancer


title: Arabidopsis_Stigma02

source_name: pistil

growth_protocol: Ovary tissues were isolated from pistils after emasculating stage 8 buds (Bowman, 1994) of Landsberg erecta (Ler) flowers. After one day of growth, pistils were harvested. Stigma was seperated from ovaries using superfine tip scissors and flash frozen in liquid nitrogen until  RNA harvesting.


title: Arabidopsis_Seedling02

source_name: seedling


title: Arabidopsis_Stigma01


title: Arabidopsis_Ovary02

source_name: plant ovary

tag: Arabidosis thaliana ovaries


title: Arabidopsis_Seedling01


title: Arabidopsis_Ovary01


title: Arabidopsis_Ovary03


title: Arabidopsis_Stigma03


title: brain, adrenal medulla: Sample#B3 (Ctrl Pt3)_e1_le1

status: Public on Jul 06 2005

first: Winnie

last: Liang

address: 445 N. Fifth Street

institute: Translational Genomics

description: Trigeminal Ganglion

organism: Mus musculus

source_name: brain, adrenal medulla


title: brain, adrenal medulla: Sample#B4(Ctrl Pt4)_e1_le1

description: Trigeminal Ganglion


title: NB4 INFECTED 3

status: Public on Jul 29 2005

city: New Haven

first: Joao

middle: Helbert

last: Pedra

state: CT

address: 300 Cedar Street - TAC S-410

department: Internal Medicine/ Rheumatology

institute: Yale University School of Medicine

description: We used the Human Genome U133 Plus 2.0 Array (Affymetrix) containing 54,675 probe sets to determine global impacts of A. phagocytophilum infection in NB4 cells at four hours post-infection.  The mRNA was isolated using the TRI reagent extraction protocol (Molecular Research Center, Cincinnati) followed by RNeasy cleanup. cRNA production, labeling reactions, hybridization, staining and washing were performed according to the Gene Chip Expression Analysis Technical Manual (Affymetrix, Santa Clara) at the W.M. Keck Facility (Yale University).  Image data were quantified by using genechip/suite microarray suite 5.0 (MAS 5.0) and default parameters were used for identification of informative probes.

source_name: NB4 PROMYELOCYTIC CELLS


title: brain, adrenal medulla: Sample#A4 (Exp pt 4)_e1_le1

description: Trigeminal Ganglion


title: wt(fgfr2)

status: Public on Jul 20 2005

city: Freiburg

first: Thomas

last: Schlake

country: Germany

institute: Max-Planck-Institute of Immunobiology

description: about 300 hair follicles from 3 mice of independent litters (about 100 hair follicles each); age: P10; RNA isolation with Trizol; probe preparation and hybridisation according to the Affymetrix protocol

source_name: pooled hair follicles, wildtype


title: NB4 INFECTED 1


title: brain, adrenal medulla: Sample#A1(Exp pt 1)_e1_le1

description: Trigeminal Ganglion


title: brain, adrenal medulla: Sample#A2 (Exp pt 2)_e1_le1

description: Trigeminal Ganglion


title: NB4 CONTROL 2


title: NB4 INFECTED 2


title: tg(fgfr2)

source_name: pooled hair follicles; dnFGFR2-IIIb transgenic mice


title: Human Cell Line, adrenal medulla: RNA613_le1

description:
dnEgr (dominant negative Egr)/EGFP infected SH-SY5Y/TrkA cells:  infection (at t=-18 hours), NGF treatment (at t=0 hours), harvest for total RNA extraction (at t=3 hours). Replicate 1
Treatment, type=add

source_name: Human Cell Line, adrenal medulla


title: brain, adrenal medulla: Sample#A3 (Exp pt 3)_e1_le1

description: Trigeminal Ganglion


title: NB4 CONTROL 3


title: Human Cell Line, adrenal medulla: RNA616_le1

description:
EGFP infected SH-SY5Y/TrkA cells:  infection (at t=-18 hours), NGF treatment (at t=0 hours), harvest for total RNA extraction (at t=3 hours). Replicate 3
Treatment, type=add


title: NB4 CONTROL 1

description:
We used the Human Genome U133 Plus 2.0 Array (Affymetrix) containing 54,675 probe sets to determine global impacts of A. phagocytophilum infection in NB4 cells at four hours post-infection.  The mRNA was isolated using the TRI reagent extraction protocol (Molecular Research Center, Cincinnati) followed by RNeasy cleanup. cRNA production, labeling reactions, hybridization, staining and washing were performed according to the Gene Chip Expression Analysis Technical Manual (Affymetrix, Santa Clara) at the W.M. Keck Facility (Yale University).  Image data were quantified by using genechip/suite microarray suite 5.0 (MAS 5.0) and default parameters were used for identification of informative probes.
The presence of transcripts was generated according to a detection p-value described in the Statistical Algorithms Reference Guide (Affymetrix, Santa Clara).  The one-sided Wilcoxon’s Signed Rank was the statistical method employed to generate detection p-values.  Transcripts with a p-value lower than 0.05 were considered present in RNA samples.  Global scaling was used to remove differences and facilitate comparison analysis.


title: brain, adrenal medulla: Sample#B2 (Ctrl Pt2)_e1_le1

description: Trigeminal Ganglion


title: Human Cell Line, adrenal medulla: RNA612_le1

description:
EGFP infected SH-SY5Y/TrkA cells:  infection (at t=-18 hours), NGF treatment (at t=0 hours), harvest for total RNA extraction (at t=3 hours). Replicate 1
Treatment, type=add


title: Diaphragm-skeletal muscle, left hemi-diaphragm: non-synaptic region_e1_le2

description: mouse left hemi-diaphragm


title: Late Embryonic tissue, epidermal: S2-NFull/S2-DI-I_3_e1_le1 - 2

hyb_protocol: not provided

scan_protocol: not provided

organism: Drosophila melanogaster

source_name: Late Embryonic tissue, epidermal

label_protocol: not provided

extract_protocol: not provided


title: Human Cell Line, adrenal medulla: RNA614_le1

description:
EGFP infected SH-SY5Y/TrkA cells:  infection (at t=-18 hours), NGF treatment (at t=0 hours), harvest for total RNA extraction (at t=3 hours). Replicate 2
Treatment, type=add


title: Late Embryonic tissue, epidermal: S2-NFull/S2-DI-I_1_e1_le1 - 2


title: Benign prostate tissue NX2

tag: Benign, pooled tissue, prostate


title: brain, adrenal medulla: Sample#B1(Ctrl Pt1)_e1_le1

description: Trigeminal Ganglion


title: Diaphragm-skeletal muscle, left hemi-diaphragm: non-synaptic region_e1_le1

description: mouse left hemi-diaphragm


title: Diaphragm-skeletal muscle, left hemi-diaphragm: synaptic region_e1_le1

description: mouse left hemi-diaphragm


title: Late Embryonic tissue, epidermal: S2-NFull/S2-DI-I_2_e1_le1 - 2


title: Human Cell Line, adrenal medulla: RNA615_le1

description:
dnEgr (dominant negative Egr)/EGFP infected SH-SY5Y/TrkA cells:  infection (at t=-18 hours), NGF treatment (at t=0 hours), harvest for total RNA extraction (at t=3 hours). Replicate 2
Treatment, type=add


title: Diaphragm-skeletal muscle, left hemi-diaphragm: synaptic region_e1_le2

description: mouse left hemi-diaphragm


title: Human Cell Line, adrenal medulla: RNA617_le1

description:
dnEgr (dominant negative Egr)/EGFP infected SH-SY5Y/TrkA cells:  infection (at t=-18 hours), NGF treatment (at t=0 hours), harvest for total RNA extraction (at t=3 hours). Replicate 3
Treatment, type=add


title: Late Embryonic tissue, epidermal: S2/S2-NdCterm_3_e1_le1


title: Late Embryonic tissue, epidermal: S2/S2_2_e1_le1


title: Late Embryonic tissue, epidermal: S2-NFull/S2_3_e1_le1


title: Late Embryonic tissue, epidermal: S2/S2-DI_3_e1_le1


title: Late Embryonic tissue, epidermal: S2-NFull/S2_1_e1_le1 - 1


title: Late Embryonic tissue, epidermal: S2/S2-DI-I_2_e1_le1


title: Late Embryonic tissue, epidermal: S2/S2-NdCterm_1_e1_le1


title: Late Embryonic tissue, epidermal: S2-NFull/S2-DI-I_1_e1_le1 - 1


title: Late Embryonic tissue, epidermal: S2-NFull/S2-DI-I_3_e1_le1 - 1


title: Late Embryonic tissue, epidermal: S2/S2_3_e1_le1


title: Late Embryonic tissue, epidermal: S2/S2_1_e1_le1


title: Late Embryonic tissue, epidermal: S2-NFull/S2_1_e1_le1 - 2


title: Late Embryonic tissue, epidermal: S2/S2-DI-I_3_e1_le1


title: Late Embryonic tissue, epidermal: S2/S2-DI_2_e1_le1


title: Late Embryonic tissue, epidermal: S2/S2-D1_1_e1_le1


title: Late Embryonic tissue, epidermal: S2-NdCterm/S2-DI_1_e1_le1


title: Late Embryonic tissue, epidermal: S2-NdCterm/S2-DI_2_e1_le1 - 1


title: Late Embryonic tissue, epidermal: S2-NdCterm/S2-DI_3_e1_le1


title: Late Embryonic tissue, epidermal: S2-NFull/S2-DI-I_2_e1_le1 - 1


title: Uterus - 5240

status: Public on Jul 01 2005

description:
Quality metric = 28S to 18S: 1.0
Patient Age: 90-100
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 14
Pathological T: 2b
Pathological N: 1
Pathological M: 0
Pathological Stage: 3C
Pathological Grade: 3
Primary Site: Endometrium
Histology: Clear cell adenocarcinoma

source_name: Endometrium


title: Ovary - 5230

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 10
Pathological T: 3c
Pathological N: 1
Pathological Grade: 3
Primary Site: Ovary
Histology: Papillary Serous Adenocarcinoma

source_name: Ovary


title: Endometrium - 4349

description:
Quality metric = 28S to 18S: 1.7
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 30
Primary Site: Endometrium
Histology: Endometrioid carcinoma


title: Uterus - 5231

description:
Quality metric = 28S to 18S: 1.5
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 30
Pathological T: 2b
Pathological N: 0
Pathological M: X
Pathological Stage: Unknown
Pathological Grade: 2
Primary Site: Endometrium
Histology: Adenosarcoma


title: Renal Pelvis - 8286

description:
Quality metric = 28S to 18S: 1.5
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Clinical Question: Stage
Clinical Value: No AJCC Staging Scheme for this Site/Histology
Primary Site: Renal Pelvis
Clinical Question: Histology
Clinical Value: Oncocytoma

source_name: Renal Pelvis


title: Ovary - 5242

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 21-25
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 28
Primary Site: Ovary
Histology: Clear cell adenocarcinoma, NOS


title: Omentum - 5232

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 60-70
Gender: Female
Ethnic Background: African-American
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 7
Presenting Symptoms: Abdominal pain
Presenting Symptoms: Bloating
Pathological T: 3c
Pathological N: 1
Pathological M: X
Pathological Stage: Unknown
Pathological Grade: 3
Primary Site: Ovary
Histology: Metastatic Serous Adenocarinoma

source_name: Omentum


title: Small Intestine - 6290

description:
Quality metric = 28S to 18S: 1.5
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Prior Therapy: Chemotherapy
Prior Therapy: Surgical
Relapse Since Primary Treatment: Yes
Number of Years Until Relapse: 0-5
Presenting Symptoms: Abdominal pain
Retreatment T: X
Retreatment N: X
Retreatment M: 1
Retreatment Metastatic Sites: Other
Retreatment Stage: 4
Retreatment Grade: 3
Primary Site: Ovary
Histology: Metastatic Adenocarcinoma

source_name: Small Intestine


title: Vulva - 5243

description:
Quality metric = 28S to 18S: 1.5
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 16-20
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 14
Primary Site: Vulva
Histology: Squamous cell carcinoma

source_name: Vulva


title: Renal Pelvis - 5244

description:
Quality metric = 28S to 18S: 1.5
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 10
Pathological T: 3
Pathological N: 2
Pathological M: X
Pathological Stage: 4
Pathological Grade: 3
Pathological Multiple Tumours: Yes
Pathological Staged During or Following Multimodality Theraphy: No
Primary Site: Renal Pelvis
Histology: Urothelial (transitional cell) carcinoma


title: Ovary - 6296

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 14
Pathological T: 3c
Pathological N: 1
Pathological M: 0
Pathological Stage: 3C
Pathological Grade: 3
Primary Site: Ovary
Histology: Papillary Serous Adenocarcinoma


title: Late Embryonic tissue, epidermal: S2-NdCterm/S2-DI_2_e1_le1 - 2


title: Ovary - 7002

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 150
Prior Therapy: Chemotherapy
Presenting Symptoms: Abdominal pain
Presenting Symptoms: Bloating
Primary Site: Ovary
Histology: Papillary Serous Adenocarcinoma


title: Ovary - 5234

description:
Quality metric = 28S to 18S: 1.6
Patient Age: 30-40
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 26-30
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: No
Pathological T: X
Pathological N: X
Pathological M: 1
Pathological Metastatic Sites: Other
Pathological Stage: 4
Pathological Grade: X
Primary Site: Stomach
Histology: Metastatic Adenocarcinoma


title: Breast - 5228

description:
Quality metric = 28S to 18S: 1.0
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 150
Prior Therapy: Chemotherapy
Mammogram: Yes
Number of years in which a mammogram was obtained?: 11-15
Oral contraceptives?: Yes
Number of years of use? (Oral contraceptives): 0-5
Oophorectomy?: Yes
Fibrocystic disease?: No
Mammogram calcifications?: No
Hormonal therapy (# of Years)?: 11-15
Pathological T: 4d
Pathological N: 1a
Pathological M: 0
Pathological Stage: 3B
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: Yes
Primary Site: Breast
Histology: Ductal Carcinoma

source_name: Breast


title: Breast - 7530

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 21
Mammogram: Yes
Number of years in which a mammogram was obtained?: 26-30
Oral contraceptives?: Yes
Number of years of use? (Oral contraceptives): 0-5
Oophorectomy?: No
Fibrocystic disease?: No
Mammogram calcifications?: No
Hormonal therapy (# of Years)?: 0-5
Primary Site: Breast
Histology: Ductal Carcinoma


title: Late Embryonic tissue, epidermal: S2-NFull/S2-DI_2_e1_le1


title: Kidney - 5227

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 21
Clinical T: 1b
Clinical N: 0
Clinical M: 0
Clinical Stage: 1
Clinical Grade: 3
Primary Site: Kidney
Histology: Conventional (clear cell) renal carcinoma

source_name: Kidney


title: Colon - 5237

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 50-60
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 0-5
Type of Tobacco Use: Cigars
Type of Tobacco Use: Pipe
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 7
Presenting Symptoms: Bright red stools
Presenting Symptoms: Diarrhea
Screening studies performed?: No
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: B
Primary Site: Colon
Histology: Adenocarcinoma

source_name: Colon


title: Colon - 5150

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 6
Presenting Symptoms: Abdominal Pain
Presenting Symptoms: Bright red stools
Presenting Symptoms: Diarrhea
Screening studies performed?: No
Diagnosis made by: Colonoscopy
Primary Site: Colon
Histology: Adenocarcinoma


title: Rectum - 4610

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 40-50
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 30
Presenting Symptoms: Constipation
Screening studies performed?: No
Diagnosis made by: Colonoscopy
Primary Site: Rectum
Histology: Adenocarcinoma

source_name: Rectum


title: Lung - 5225

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 56-60
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 60
Workplace or household smokers?: Yes
Pathological T: 1
Pathological N: 2
Pathological M: 0
Pathological Stage: 3A
Pathological Grade: 3
Primary Site: Lung
Histology: Adenocarcinoma, NOS

source_name: Lung


title: Lung - 4451

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 60-70
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 51-55
Type of Tobacco Use: Cigarettes
Type of Tobacco Use: Pipe
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 24
Presenting Symptoms: Persistent Cough
Workplace or household smokers?: Yes
Pathological T: 3
Pathological N: 1
Pathological M: 0
Pathological Stage: 3A
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Lung
Histology: Squamous cell carcinoma


title: Uterus - 5233

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Pathological T: 2a
Pathological N: 0
Pathological M: X
Pathological Stage: Unknown
Pathological Grade: 1
Primary Site: Endometrium
Histology: Endometrioid carcinoma


title: Ovary - 4346

description:
Quality metric = 28S to 18S: 1.5
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 3
Presenting Symptoms: Abdominal mass
Presenting Symptoms: Bloating
Primary Site: Ovary
Histology: Papillary Serous Carcinoma


title: Omentum - 4347

description:
Quality metric = 28S to 18S: 1.8
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 19
Presenting Symptoms: Bloating
Primary Site: Ovary
Histology: Metastatic Papillary Serous Carcinoma


title: Breast - 4227

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 80-90
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 14
Mammogram: Yes
Number of years in which a mammogram was obtained?: 11-15
Oral contraceptives?: Yes
Number of years of use? (Oral contraceptives): 11-15
Oophorectomy?: No
Fibrocystic disease?: No
Mammogram calcifications?: No
Primary Site: Breast
Histology: Lobular Carcinoma


title: Ovary - 4195

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 70-80
Gender: Female
Ethnic Background: Asian
Tobacco Use : Yes
Years of Tobacco Use: 11-15
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 30
Presenting Symptoms: Vaginal bleeding
Clinical T: 2
Clinical N: 0
Clinical M: 0
Clinical Stage: 2
Clinical Grade: 3
Primary Site: Ovary
Histology: Papillary Serous Carcinoma


title: Tongue - 4216

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 60-70
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 36-40
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 28
Pathological T: 1
Pathological N: 0
Pathological Grade: 1
Pathological Multiple Tumours: No
Pathological Staged During or Following Multimodality Theraphy: No
Primary Site: Tongue
Histology: Squamous cell carcinoma

source_name: Tongue


title: Uterus - 4344

description:
Quality metric = 28S to 18S: 1
Patient Age: 80-90
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 31-35
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 44
Primary Site: Endometrium
Histology: Endometrioid carcinoma

source_name: Uterus


title: Prostate - 4337

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 60-70
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 16-20
Type of Tobacco Use: Cigarettes
Type of Tobacco Use: Pipe
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 165
PSA: Elevated
# of years PSA Tested?: 0-5
Cancer discovered by digital exam?: No
Current status of disease: Under Therapy
Primary Site: Prostate
Histology: Adenocarcinoma, Acinar Type

source_name: Prostate


title: Prostate - 4196

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 50-60
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 16-20
Type of Tobacco Use: Cigarettes
Type of Tobacco Use: Cigars
Type of Tobacco Use: Pipe
Alcohol Consumption?: Yes
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 42
Prior Therapy: Hormonal Treatment
Presenting Symptoms: Dribbling
Presenting Symptoms: Nocturia
PSA: Elevated
# of years PSA Tested?: 0-5
Cancer discovered by digital exam?: No
Current status of disease: Under Therapy
Pathological T: 3b
Pathological N: 0
Pathological M: 0
Pathological Stage: 3
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: Yes
Pathological Gleason Score: 8-10
Primary Site: Prostate
Histology: Adenocarcinoma, NOS


title: Breast - 4226

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 15
Mammogram: Yes
Number of years in which a mammogram was obtained?: 21-25
Oral contraceptives?: Yes
Number of years of use? (Oral contraceptives): 0-5
Oophorectomy?: Yes
Fibrocystic disease?: No
Mammogram calcifications?: No
Hormonal therapy (# of Years)?: 0-5
Primary Site: Breast
Histology: Ductal Carcinoma


title: Ovary - 4342

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 16-20
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 39
Primary Site: Ovary
Histology: Papillary Serous Carcinoma


title: Colon - 4214

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 60-70
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 11-15
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 18
Presenting Symptoms: Diarrhea
Diagnosis made by: Colonoscopy
Primary Site: Colon
Histology: Adenocarcinoma


title: Breast - 4219

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Mammogram: Yes
Number of years in which a mammogram was obtained?: 6-10
Oral contraceptives?: No
Oophorectomy?: No
Fibrocystic disease?: No
Mammogram calcifications?: No
Primary Site: Breast
Histology: Ductal Carcinoma


title: Endometrium - 4204

description:
Quality metric = 28S to 18S: 1.5
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 30
Primary Site: Endometrium
Histology: Endometrioid carcinoma